Medication therapy of allergic rhinitis in children
https://doi.org/10.21518/2079-701X-2015-1-72-75
Abstract
Allergic rhinitis is a widespread chronic pathology of the upper respiratory tract in children and adults. In a number of countries, more than 50% of the population have clinical manifestations of allergic rhinitis. [1] According to Russian authors, the prevalence of allergic rhinitis in Russia in different regions varies between 10-40% of the pediatric population [2]. Moreover, according to the latest projections, if the trend for annual growth of allergic rhinitis in Europe persists, one child who does not have allergic rhinitis will account for 3 children with allergic rhinitis. [3]
About the Authors
D. A. Tulupov
Russian Medical Academy of Postgraduate Education, department of pediatric otorhinolaryngology, Moscow
Russian Federation
Russian Federation
E. P. Karpova
Russian Medical Academy of Postgraduate Education, department of pediatric otorhinolaryngology, Moscow
Russian Federation
Russian Federation
References
1. Bousquet J, Khaltaev N, Cruz AA, Denburg J et al. World Health Organization; GA(2)LEN; AUerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy, 2008, 63(86): 8-160.
2. Ильина Н.И. Эпидемиология аллергического ринита. Российская ринология. 1999, 1: 23-25.
3. Canonica GW, Passalacqua G, Baiardini I, Senna G. Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis. Clin Exp Allergy. 2013, 43(1): 22-28.
4. Kern R. Allergy: a constant factor in the etiology of so-called mucous nasal polyps. J Allergy. 1993, 4: 483.
5. Caffarelli C, Savini E, Giordano S, Gianlupi G, Cavagni G. Atopy in children with otitis media with effusion. Clin Exp Allergy. 1998, 28(5): 591596.
6. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007, 62(85): 17-25.
7. Aberg N, Sundell J, Eriksson B, Hesselmar B, Aberg B. Prevalence of allergic diseases in school children in relation to family history, upper respiratory infections, and residential characteristics. Allergy. 1996, 51(4): 232-237.
8. Tran NP, Vickery J, Blaiss MS. Management of Rhinitis: Allergic and Non-Allergic. Allergy Asthma Immunol Res. 2011, 3(3): 148-156.
9. Okubo K, Kurono Y, Fujieda S, Ogino S, Uchio E, Odajima H, Takenaka H, Baba K. Japanese Guideline for Allergic Rhinitis. Allergology International. 2011, 60: 171-189.
10. Fokkens W, Lund V, Mullol J, Bachert C et al. European position paper on rhinosinusitis and nasal polyps 2012 (Ep3OS). Rhinology. 2012, 50(23): 1-299.
11. Карпова Е.П. Лечение аллергического ринита у детей (руководство для врачей). М.: Гэотар-медиа, 2007.
12. Карпова Е.П., Соколова М.В., Антонова Н.В. Особенности терапии аллергического ринита у детей. Вестник оториноларингологии. 2009, 2: 36-39.
13. Marchisio P, Varricchio A, Baggi E et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. Int J Immunopathol Pharmacol. 2012, 25(3): 721-730.
14. Brozek JL, Bousquet J, Baena-Cagnani CE et al. Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010, 126(3): 466-476.
15. Карпова Е.П., Тулупов Д.А. Назальные сосудосуживающие препараты в педиатрической практике. Эффективная фармакотерапия. Педиатрия. 2012, 1: 18-24.
16. Ревякина В.А. Антигистаминные препараты в клинической практике. Дискуссионные вопросы. Взгляд врача на привычные препараты. Лечащий врач. 2010, 7: 71-73.
17. Gonzalez MA, Estes KS. Pharmacokinetic overview of oral second-generation H1 antihista-mines. Int J Clin Pharmacol Ther. 1998, 36(5): 292-300.
18. Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children. Drug Saf. 2001, 24(2): 119-147.
19. Greisner WA. Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines. Allergy Asthma Proc. 2004, 25(2): 81-83.
20. Golightly LK, Greos LS. Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Drugs. 2005, 65(3): 341-384.
21. Sastre J, Mosges R. Local and Systemic Safety of Intranasal Corticosteroids. J InvestigAllergol Clin Immunol 2012, 22(1): 1-12.
22. Wolthers OD. Relevance of pharmacokinetics and bioavailability of intranasal corticosteroids in allergic rhinitis. Recent Pat Inflamm Allergy Drug Discov. 2010, 4(2): 118-123.
Review
For citations:
Tulupov DA, Karpova EP. Medication therapy of allergic rhinitis in children. Meditsinskiy sovet = Medical Council. 2015;(1):72-75. (In Russ.) https://doi.org/10.21518/2079-701X-2015-1-72-75
Views:
453
Email this article 